ASCO: Bladder Sparing Studied in Muscle - Invasive Bladder Cancer

Transurethral resection then gemcitabine, cisplatin, plus nivolumab with intact bladder in selected patients studied in phase 2 trial
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pathology, Pharmacy, Urology, Conference News, Source Type: news